Literature DB >> 28646346

Adenosine and Sleep.

Michael Lazarus1, Jiang-Fan Chen2,3, Zhi-Li Huang4, Yoshihiro Urade5, Bertil B Fredholm6.   

Abstract

The classic endogenous somnogen adenosine promotes sleep via A1 and A2A receptors. In this chapter, we present an overview of the current knowledge regarding the regulation of adenosine levels, adenosine receptors, and available pharmacologic and genetic tools to manipulate the adenosine system. This is followed by a summary of current knowledge of the role of adenosine and its receptors in the regulation of sleep and wakefulness. Despite strong data implicating numerous brain areas, including the basal forebrain, the tuberomammillary nucleus, the lateral hypothalamus, and the nucleus accumbens, in the adenosinergic control of sleep, the complete neural circuitry in the brain involved in the sleep-promoting effects of adenosine remains unclear. Moreover, the popular demand for natural sleep aids has led to a search for natural compounds that can promote sleep via adenosine receptor activation. Finally, we discuss the effects of caffeine in man and the possible use of more selective adenosine receptor drugs for the treatment of sleep disorders.

Entities:  

Keywords:  Adeno-associated virus; Astrocytes; CGS 21680; DREADD; Istradefylline; Modafinil; Non-rapid eye movement sleep; Optogenetics; Prostaglandin D2; Slow-wave sleep

Mesh:

Substances:

Year:  2019        PMID: 28646346     DOI: 10.1007/164_2017_36

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  17 in total

Review 1.  Neuroendocrine Control of Sleep.

Authors:  Philip C Smith; Jessica A Mong
Journal:  Curr Top Behav Neurosci       Date:  2019

2.  The Arousal-motor Hypothesis of Dopamine Function: Evidence that Dopamine Facilitates Reward Seeking in Part by Maintaining Arousal.

Authors:  Marcin Kaźmierczak; Saleem M Nicola
Journal:  Neuroscience       Date:  2022-07-16       Impact factor: 3.708

3.  Raw Pinelliae Rhizoma: examination of sedative and hypnotic effects in mice and chemical analysis.

Authors:  Sisi Lin; Haipeng Chen; Bo Nie; Chengrou Jiang; Hui Yang; Qinglai Wang; Zhengzhong Yuan
Journal:  Sleep Breath       Date:  2022-09-27       Impact factor: 2.655

4.  Adenosine Downregulates the Activities of Glutamatergic Neurons in the Paraventricular Hypothalamic Nucleus Required for Sleep.

Authors:  Changlin Chen; Yichen Lin; Feng Cai; Jinsui Li; Haixun Li; Xiantao Li
Journal:  Front Neurosci       Date:  2022-06-13       Impact factor: 5.152

Review 5.  Possible Neuropathology of Sleep Disturbance Linking to Alzheimer's Disease: Astrocytic and Microglial Roles.

Authors:  Shu-Yun Xiao; Yi-Jie Liu; Wang Lu; Zhong-Wei Sha; Che Xu; Zhi-Hua Yu; Shin-Da Lee
Journal:  Front Cell Neurosci       Date:  2022-06-09       Impact factor: 6.147

6.  Estradiol influences adenosinergic signaling and nonrapid eye movement sleep need in adult female rats.

Authors:  Philip C Smith; Derrick J Phillips; Ana Pocivavsek; Carissa A Byrd; Shaun S Viechweg; Brian Hampton; Jessica A Mong
Journal:  Sleep       Date:  2022-03-14       Impact factor: 6.313

Review 7.  Adenosine A2A receptor antagonists: from caffeine to selective non-xanthines.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Pierre Matricon; Matthew T Eddy; Jens Carlsson
Journal:  Br J Pharmacol       Date:  2020-06-19       Impact factor: 9.473

8.  Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins.

Authors:  Estefanía Moreno; Júlia Canet; Eduard Gracia; Carme Lluís; Josefa Mallol; Enric I Canela; Antoni Cortés; Vicent Casadó
Journal:  Front Pharmacol       Date:  2018-02-15       Impact factor: 5.810

Review 9.  Role of Adenosine in Epilepsy and Seizures.

Authors:  Fabio C Tescarollo; Diogo M Rombo; Lindsay K DeLiberto; Denise E Fedele; Enmar Alharfoush; Ângelo R Tomé; Rodrigo A Cunha; Ana M Sebastião; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2020-06-04

10.  Headache outcomes of a sleep behavioral intervention in breast cancer survivors: Secondary analysis of a randomized clinical trial.

Authors:  Yohannes W Woldeamanuel; Douglas W Blayney; Booil Jo; Sophie E Fisher; Catherine Benedict; Ingrid Oakley-Girvan; Shelli R Kesler; Oxana Palesh
Journal:  Cancer       Date:  2021-08-06       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.